Having identified specific NPC signatures in the control and patient PAX6-GFP sorted cells, we used this system to compare the expression profiles between purified control and patient NPCs to identify potentially disease-relevant differences. This evidence concerns the gene PAX6 and nasopharyngeal carcinoma.